ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Henderson Committee Final Recommendation Made On P01s

February 10, 1984

Michael Grever To Head DTP; Chabner’s Deputy Is Kaufman; Radiation Program To Be Split

April 5, 1991

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

December 11, 1987

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

October 3, 2014

Henschke and Supporters Call For Urgent Action Based On Results Of NLST

May 13, 2011